首页> 外文期刊>Journal of neuroimaging >Saline versus Saline with Blood as a Contrast Agent for Right-to-left Shunt Diagnosis by Transcranial Doppler: Is There a Significant Difference?
【24h】

Saline versus Saline with Blood as a Contrast Agent for Right-to-left Shunt Diagnosis by Transcranial Doppler: Is There a Significant Difference?

机译:盐水与盐水对比造影剂通过经颅多普勒诊断从右向左分流:有显着差异吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Background and purpose: Agitated saline solution (AS) is the contrast agent (CA) of choice for the diagnosis of right-to-left shunt (RLS). The aim of this study was to compare AS to AS with blood (ASb) in the diagnosis and quantification of RLS by contrast-enhanced transcranial Doppler (cTCD). Methods: Forty-two patients were evaluated for RLS in both of the middle cerebral arteries (MCA) by cTCD. Both AS and ASb were used as CAs while the patient breathed spontaneously and during two different moments of a Valsalva maneuver. Embolus track (ET) counts were obtained from each MCA (MCA analysis) and from each patient (patient analysis). Results: In the MCA analysis, at least one ET was identified in 109 (43.2%) of the AS tests and 136 (54%) of the ASb tests (P= .016). The ET counts were higher with ASb (78.0 ± 117.6) than with AS alone (46.9 ± 66.7; P= .01). In the patient analysis, at least one ET was identified in 62 (49.2%) of the AS tests and 77 (61.1%) of the ASb tests (P= .057). Similar ET counts were generated with both CA solutions. Conclusions: These findings support the inclusion of ASb as an option for RLS diagnosis in selected patients.
机译:背景与目的:搅动盐溶液(AS)是诊断从右向左分流(RLS)的首选造影剂(CA)。这项研究的目的是通过造影剂增强型经颅多普勒(cTCD)对AS与AS与血液(ASb)的诊断和定量RLS进行比较。方法:通过cTCD对42例患者的两个大脑中动脉(MCA)的RLS进行了评估。在患者自发呼吸以及在瓦尔萨尔瓦动作的两个不同时刻,AS和ASb均用作CA。从每个MCA(MCA分析)和每个患者(患者分析)获得栓子跟踪(ET)计数。结果:在MCA分析中,至少有109个ET被鉴定为109(43.2%)的AS测试和136(54%)为ASb的测试(P = 0.016)。 ASb的ET计数(78.0±117.6)比单独使用AS的ET计数高(46.9±66.7; P = .01)。在患者分析中,在62例(49.2%)的AS测试和77例(61.1%)的ASb测试中至少鉴定出一种ET(P = .057)。两种CA解决方案都产生了相似的ET计数。结论:这些发现支持在选定的患者中将ASb作为RLS诊断的一种选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号